EIPM's Fourth Quarter External Newsletter
January 6, 2023
Dear Friend of the Englander Institute for Precision Medicine,
Welcome to our final quarterly external newsletter of 2022!
January 2023 EIPM Director's Memo
January 2, 2023
Dear Members of the Englander Institute,
As we begin the new year I’d like to thank everyone for their hard work, productivity, and dedication to our mission. It’s a great pleasure to work along side you, and I can hardly wait to see what the new year brings!
Enzyme That Protects Against Viruses Could Fuel Cancer Evolution
December 28, 2022
An enzyme that defends human cells against viruses can help drive cancer evolution towards greater malignancy by causing myriad mutations in cancer cells, according to a study led by investigators at Weill Cornell Medicine. The finding suggests that the enzyme may be a potential target for future cancer treatments.
A Conversation with Grad Student Matt Wickersham
December 20, 2022
We are pleased to bring you this Conversation with Matt Wickersham, a graduate student who has worked in the lab of our Director Olivier Elemento, Ph.D., and who established the Weill Cornell Medicine Wellness Qlinic, the first student-run clinic focused on addressing the mental health disparities faced by the lesbian, gay, bisexual, transgender, and queer (LGBTQ+) communities in New York City. Matt was nominated for the Forbes 30 Under 30 list within the Social Justice category.
Harnessing Artificial Intelligence Technology for IVF Embryo Selection
December 19, 2022
An artificial intelligence algorithm can determine non-invasively, with about 70 percent accuracy, if an in vitro fertilized embryo has a normal or abnormal number of chromosomes, according to a new study from researchers at Weill Cornell Medicine.
December 2022 EIPM Director's Memo
December 1, 2022
Dear Members of the Englander Institute,
As we begin the last month of the year I’d like to thank all of you for your hard work, productivity, and dedication to our mission. It’s a great pleasure to work along side you, and I can hardly wait to see what the new year brings for us!
This month’s EIPM Director’s Memo highlights new grants from the NIH, NCI, and the CTSC, impressive news media coverage of our work, speaking events at major conferences, and exciting publications in leading journals.
November 2022 EIPM Director's Memo
November 1, 2022
Dear Members of the Englander Institute,
I’m really happy to share this month’s EIPM Director’s Memo with you because there are so many great new initiatives, partnerships, news coverage, events, and publications to celebrate!
New Computational Method Builds Detailed Maps of Human Tissues
October 31, 2022
Weill Cornell Medicine researchers have developed a computational method to map the architecture of human tissues in unprecedented detail. Their approach promises to accelerate studies on organ-scale cellular interactions and could enable powerful new diagnostic strategies for a wide range of diseases.
EIPM Researchers find Corrupt Endothelial Cells Protect Blood Cancer Cells from Chemotherapy
October 17, 2022
Endothelial cells—the cells that line blood vessels—grown alongside leukemia cells become corrupted and rescue the cancer cells from many chemotherapy drugs, a study by Weill Cornell Medicine investigators found.
MCC and EIPM Wrap-Up Successful 2022 Summer Program
October 17, 2022
The Meyer Cancer Center (MCC) and Englander Institute for Precision Medicine (EIPM) recently wrapped up their annual 6-week summer program for approximately 50 high school juniors and seniors, and college students. Designed to improve education related to cancer and precision medicine, the hybrid summer program provides mentorship, and encourages the pursuit of STEM careers.